BIOR - Biora Therapeutics Inc. (BIOR) Q1 2024 Earnings Call Transcript
2024-05-15 18:29:12 ET
Biora Therapeutics, Inc. (BIOR)
Q1 2024 Earnings Conference Call
May 15, 2024, 4:30 PM ET
Company Participants
Chuck Padala - Managing Director, LifeSci Advisors
Adi Mohanty - Chief Executive Officer
Eric d'Esparbes - Chief Financial Officer
Conference Call Participants
Joseph Pantginis - H.C. Wainwright
Rei Tan - BTIG
John Vandermosten - Zacks
Presentation
Operator
Greetings and welcome to Biora Therapeutics First Quarter 2024 Financial Results Call. At this time, all participants are in listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a remainder, this conference is being recorded.
I will now turn the call over to Chuck Padala, Managing Director with LifeSci Advisors, Biora's Investor Relations firm. Please go ahead.
Chuck Padala
Thank you, operator. Good afternoon and welcome to the Biora Therapeutics First Quarter 2024 Corporate Update and Financial Results Conference Call. Joining me on the call are Adi Mohanty, Chief Executive Officer; and Eric d'Esparbes, Chief Financial Officer.
Before I turn the call over to Mr. Mohanty, I would like to remind you that today's call will include forward-looking statements within the meaning of the federal securities laws, including, but not limited to, the types of statements identified as forward-looking in our quarterly report on Form 10-Q that we filed or will file later today and our subsequent reports filed with the SEC, which are available on our website in the Investors section....
Biora Therapeutics, Inc. (BIOR) Q1 2024 Earnings Call Transcript